Skip to main content

Table 1 Subcategories and definitions by WHO MA subtask

From: Glancing at the past and course-setting for the future: lessons from the last decade of research on medication abortion in high-income countries

Category Subcategory Definition
WHO Subtask 1. Assessing eligibility Eligibility assessment Using different mechanisms, such as LMP and pelvic bimanual versus ultrasound to determine eligibility for early MA
WHO Subtask 2: Administering the medications and managing the process and common side-effects Clinical management Safety and efficacy Testing different clinical innovations and regimens for MA
Feasibility Practicability of administration of mifepristone-misoprostol or misoprostol-only regimens on MA in various situations and contexts
Management of side effects and complications Self-administration of medication and self-management of pain, bleeding, expulsion of the products of conception, and self-identification of the need to seek formal healthcare for potential complications
Models of service delivery Facility-based models Assessment of different models of facility-based provision of MA
Information and counseling Models of providing and receiving information on MA before undergoing the procedure
Online and telemedicine provision Provision or acquisition of MA pills and/or information about the procedure via website or via telemedicine, i.e. providers using telecommunications technology to interact with patients remotely
Home use Safety, effectiveness and experiences of administration of mifepristone-misoprostol or misoprostol-only regimens by an individual at home. This also includes partial self-administration
Pharmacy provision Documentation of sourcing of MA from pharmacists or pharmacies, regardless of the legal context
WHO Subtask 3: Assessing completion of the procedure and the need for further clinic-based follow-up Failure and adverse events related to MA Prevalence and characteristics of adverse events, including failure and need for surgical intervention, hospital admission, blood transfusion, emergency department treatment, intravenous antibiotics administration, infection, and death, as follow-on events from cases of self-administration of combined regimen and/or misoprostol-only induced abortions
Post-abortion follow-up using β-hCG Using serum hCG measurements for monitoring of abortion completion versus or in place of ultrasonography
Models for post-abortion follow-up Effectiveness of different types of MA service delivery follow-up options, e.g. home pregnancy test, checklists, bimanual or speculum examination by provider, telephone follow up etc. to assess completion
Ultrasound Techniques or technology associated with conducting and/or reading ultrasound as part of the MA process – only for completion
Post-MA contraception Take up, safety and acceptability of contraceptive methods after MA
Other clinical Prevalence Analyses of proportions of a population experiencing (aspects of) MA; can include subgroup analyses, and association and correlations with other factors
MA in particular populations Analyses of the safety, efficacy, acceptability and service delivery options for certain sub-groups of a given population
Surgical vs. medical abortion Comparison of surgical and MA regarding factors such as preference, access, acceptability, safety, efficacy etc
Social science Knowledge, attitudes and practices Assessing the awareness, views and behaviors of different populations regarding MA among women, partners, providers and relevant others
Women's preferences and experiences with MA Measure of preferences regarding MA among women who have used it
Legal/policy context Related to laws and policies governing MA
Cost-effectiveness Economic analyses of relative costs and outcomes of different aspects of the delivery and/or receipt of MA care // Documentation of the degree to which a specific aspect of MA is good value for the resources required